{"id":64979,"date":"2015-10-12T12:00:48","date_gmt":"2015-10-12T11:00:48","guid":{"rendered":"https:\/\/www.transcend.org\/tms\/?p=64979"},"modified":"2015-10-12T08:03:49","modified_gmt":"2015-10-12T07:03:49","slug":"tpp-treaty-intellectual-property-rights-chapter","status":"publish","type":"post","link":"https:\/\/www.transcend.org\/tms\/2015\/10\/tpp-treaty-intellectual-property-rights-chapter\/","title":{"rendered":"TPP Treaty: Intellectual Property Rights Chapter"},"content":{"rendered":"<p>Today, 9 October, 2015 WikiLeaks releases the final negotiated text for the TPP (Trans-Pacific Partnership) Intellectual Property Rights Chapter. The TPP encompasses 12 nations representing more than 40 per cent of global GDP. Despite a final agreement, the text is still being withheld from the public, notably until after the Canadian election on October 19.<\/p>\n<p><a href=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2015\/10\/WikiLeaks-TPP-IP-Chapter-pharmaceutical-generic-treaties.gif\" ><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-64980\" src=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2015\/10\/WikiLeaks-TPP-IP-Chapter-pharmaceutical-generic-treaties-1024x787.gif\" alt=\"WikiLeaks-TPP-IP-Chapter pharmaceutical generic treaties\" width=\"700\" height=\"538\" srcset=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2015\/10\/WikiLeaks-TPP-IP-Chapter-pharmaceutical-generic-treaties-1024x787.gif 1024w, https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2015\/10\/WikiLeaks-TPP-IP-Chapter-pharmaceutical-generic-treaties-300x230.gif 300w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><\/a><\/p>\n<p>The document is dated four days ago, October 5th, or last Monday, the same day it was announced in Atlanta, Georgia that the 12 member states to the treaty had reached an accord after five and a half years of negotiations.<\/p>\n<p>The IP Chapter of the TPP has perhaps been the most controversial chapter due to its wide-ranging effects on internet services, medicines, publishers, civil liberties and biological patents. \u201cIf TPP is ratified, people in the Pacific-Rim countries would have to live by the rules in this leaked text,\u201d said Peter Maybarduk, Public Citizen\u2019s Global Access to Medicines Program Director. \u201cThe new monopoly rights for big pharmaceutical firms would compromise access to medicines in TPP countries. The TPP would cost lives.\u201d<\/p>\n<p>Hundreds of representatives from large corporations had direct access to the negotiations whereas elected officials had limited or no access. Political opposition to the TPP in the United States, the dominant member of the 12 negotiating nations, has increased over time as details have emerged through previous WikiLeaks disclosures. Notably, the Democratic front runner, Hillary Clinton, came out against the TPP on Wednesday saying: \u201cBased on what I know so far, I can\u00b4t support this agreement.\u201d This is a populist reversal by Hillary Clinton as earlier she has hailed the TPP as \u201cthe gold standard in trade agreements\u201d.<\/p>\n<p>In June the House of Representatives of the US Congress narrowly approved to \u201cfast-track\u201d the TPP, preventing the Congressmen from discussing or amending any parts of the treaty, only vote for or against it. 218 voted for the \u201cfast-track\u201d measure and 208 against. Only 28 House Democrats backed it. TPP is the first of a trinity of US backed economic treaties, the &#8220;Three Big T\u2019s&#8221;, to be finalized. The other two being Trade in Services Agreement (TISA) which covers 52 countries and TTIP, the EU-US version of TPP.<\/p>\n<p><a href=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2015\/10\/TPP-Intellectual-Property-chapter-5.jpg\" ><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-64981\" src=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2015\/10\/TPP-Intellectual-Property-chapter-5-1024x683.jpg\" alt=\"TPP Intellectual Property chapter 5\" width=\"700\" height=\"467\" srcset=\"https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2015\/10\/TPP-Intellectual-Property-chapter-5.jpg 1024w, https:\/\/www.transcend.org\/tms\/wp-content\/uploads\/2015\/10\/TPP-Intellectual-Property-chapter-5-300x200.jpg 300w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><\/a><\/p>\n<p>View the leaked &#8220;TPP Treaty: Intellectual Property Rights Chapter, Consolidated Text&#8221; (<a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/WikiLeaks-TPP-IP-Chapter\/WikiLeaks-TPP-IP-Chapter-051015.pdf\" >PDF<\/a>, <a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/WikiLeaks-TPP-IP-Chapter\/page-1.html\" >HTML<\/a>).<\/p>\n<p><strong>Experts Analysis<\/strong><\/p>\n<p>Expert Analysis: &#8220;Ambiguity Leads to Fallacy: Biologics Exclusivity in the Trans-Pacific Partnership&#8221; (<a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/biologics\/Ambiguity%20Leads%20to%20Fallacy%20%28Biologics%29.pdf\" >PDF<\/a>, <a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/biologics\/page-1.html\" >HTML<\/a>).<\/p>\n<p>Expert Analysis: &#8220;Pharmaceutical Provisions in the TPP&#8221; (<a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/pharmaceutical\/Pharmaceutical%20Provisions%20in%20the%20TPP.pdf\" >PDF<\/a>, <a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/pharmaceutical\/page-1.html\" >HTML<\/a>).<\/p>\n<p>Expert Analysis: &#8220;TPP Transition Periods on Pharmaceutical Intellectual Property Rules&#8221; (<a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/pharmaceutical-transition\/TPP%20Transition%20Periods%20on%20Pharmaceuticals.pdf\" >PDF<\/a>, <a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/pharmaceutical-transition\/page-1.html\" >HTML<\/a>).<\/p>\n<p>Expert Analysis: &#8220;International Convention for the Protection of New Varieties of Plants 1991 (UPOV91)&#8221; (<a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/upov\/UPOV%20and%20NZ.pdf\" >PDF<\/a>, <a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/upov\/page-1.html\" >HTML<\/a>).<\/p>\n<p>Expert Analysis: &#8220;Propiedad intelectual en el Tratado Transpac\u00edfico&#8221; (<a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/propiedad-intelectual\/Propiedad-intelectual-en-el-Tratado-Transpacifico.pdf\" >PDF<\/a>, <a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/propiedad-intelectual\/page-1.html\" >HTML<\/a>)<\/p>\n<p>Expert Analysis: &#8220;Public Citizen &#8211; WikiLeaks Publication of Complete, Final TPP Intellectual Property&#8221; (<a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/pcpressrelease\/Public-Citizen-Statement-on-WikiLeaks-TPP-Publication.pdf\" >PDF<\/a>, <a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/pcpressrelease\/page-1.html\" >HTML<\/a>)<\/p>\n<p><a target=\"_blank\" href=\"https:\/\/wikileaks.org\/tpp-ip3\/\" >Go to Original \u2013 wilileaks.org<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Today, 9 October, 2015 WikiLeaks releases the final negotiated text for the TPP (Trans-Pacific Partnership) Intellectual Property Rights Chapter. The document is dated October 5, last Monday. This has been perhaps the most controversial chapter due to its wide-ranging effects on internet services, medicines, publishers, civil liberties and biological patents<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[169],"tags":[],"class_list":["post-64979","post","type-post","status-publish","format-standard","hentry","category-trade"],"_links":{"self":[{"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/posts\/64979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/comments?post=64979"}],"version-history":[{"count":0,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/posts\/64979\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/media?parent=64979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/categories?post=64979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transcend.org\/tms\/wp-json\/wp\/v2\/tags?post=64979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}